{"id":35711,"date":"2025-06-20T15:37:37","date_gmt":"2025-06-20T07:37:37","guid":{"rendered":"https:\/\/flcube.com\/?p=35711"},"modified":"2025-06-20T15:37:38","modified_gmt":"2025-06-20T07:37:38","slug":"beijing-science-sun-pharma-inks-rmb20m-drug-tech-transfer-pact-for-neoab33-project","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=35711","title":{"rendered":"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project"},"content":{"rendered":"\n<p>Beijing Science Sun Pharmaceutical Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/300485:SHE\">SHE: 300485<\/a>) announced a Drug Technology Transfer Agreement with its equity-affiliated company Beijing Protein Innovation Co., Ltd. The deal secures all related technologies for the NeoAB33 novel drug project for a total consideration of RMB20 million (USD 2.6 million).<\/p>\n\n\n\n<p><strong>Transaction Details<\/strong><br>The agreement encompasses the design, modification, and production technologies for the protein linked to research code NeoAB33. This Category 1 biological product is under development for treating acute ischemic stroke (AIS) and microcirculation disorders. These disorders include diabetes-induced nephropathy, peripheral neuropathy, retinopathy\/ocular fundus diseases, and as adjuvant therapy for hypertension.<\/p>\n\n\n\n<p><strong>Drug Mechanism<\/strong><br>The protein can release bradykinin and lysine bradykinin from kininogen. It promotes blood flow through immediate vasodilation and long-term angiogenesis, increasing blood flow to various tissues such as the brain, kidney, and heart. It also activates downstream pathways to perform physiological functions like dilating capillaries, relaxing vascular smooth muscle, increasing blood flow, lowering blood pressure, anticoagulation, thrombolysis, and reducing blood viscosity.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u8d5b\u5347\u836f\u4e1a\uff1a\u5173\u4e8e\u7b7e\u8ba2\u300a\u65b0\u836f\u6280\u672f\u8f6c\u8ba9\u5408\u540c\u300b\u66a8\u5173\u8054\u4ea4\u6613\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u8d5b\u5347\u836f\u4e1a\uff1a\u5173\u4e8e\u7b7e\u8ba2\u300a\u65b0\u836f\u6280\u672f\u8f6c\u8ba9\u5408\u540c\u300b\u66a8\u5173\u8054\u4ea4\u6613\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-74ef11c7-f56e-4fb2-857f-ba369d195756\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u8d5b\u5347\u836f\u4e1a\uff1a\u5173\u4e8e\u7b7e\u8ba2\u300a\u65b0\u836f\u6280\u672f\u8f6c\u8ba9\u5408\u540c\u300b\u66a8\u5173\u8054\u4ea4\u6613\u7684\u516c\u544a.pdf\">\u8d5b\u5347\u836f\u4e1a\uff1a\u5173\u4e8e\u7b7e\u8ba2\u300a\u65b0\u836f\u6280\u672f\u8f6c\u8ba9\u5408\u540c\u300b\u66a8\u5173\u8054\u4ea4\u6613\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/\u8d5b\u5347\u836f\u4e1a\uff1a\u5173\u4e8e\u7b7e\u8ba2\u300a\u65b0\u836f\u6280\u672f\u8f6c\u8ba9\u5408\u540c\u300b\u66a8\u5173\u8054\u4ea4\u6613\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-74ef11c7-f56e-4fb2-857f-ba369d195756\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Beijing Science Sun Pharmaceutical Co., Ltd (SHE: 300485) announced a Drug Technology Transfer Agreement with&#8230;<\/p>\n","protected":false},"author":1,"featured_media":35713,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,11],"tags":[69,3755,3756],"class_list":["post-35711","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-drug","tag-cvd","tag-science-sun-pharmaceutical","tag-she-300485"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Beijing Science Sun Pharmaceutical Co., Ltd (SHE: 300485) announced a Drug Technology Transfer Agreement with its equity-affiliated company Beijing Protein Innovation Co., Ltd. The deal secures all related technologies for the NeoAB33 novel drug project for a total consideration of RMB20 million (USD 2.6 million).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=35711\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project\" \/>\n<meta property=\"og:description\" content=\"Beijing Science Sun Pharmaceutical Co., Ltd (SHE: 300485) announced a Drug Technology Transfer Agreement with its equity-affiliated company Beijing Protein Innovation Co., Ltd. The deal secures all related technologies for the NeoAB33 novel drug project for a total consideration of RMB20 million (USD 2.6 million).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=35711\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-20T07:37:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-20T07:37:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2012.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project\",\"datePublished\":\"2025-06-20T07:37:37+00:00\",\"dateModified\":\"2025-06-20T07:37:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711\"},\"wordCount\":177,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/2012.webp\",\"keywords\":[\"CVD\",\"Science Sun Pharmaceutical\",\"SHE: 300485\"],\"articleSection\":[\"Company\",\"Deals\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=35711#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=35711\",\"name\":\"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/2012.webp\",\"datePublished\":\"2025-06-20T07:37:37+00:00\",\"dateModified\":\"2025-06-20T07:37:38+00:00\",\"description\":\"Beijing Science Sun Pharmaceutical Co., Ltd (SHE: 300485) announced a Drug Technology Transfer Agreement with its equity-affiliated company Beijing Protein Innovation Co., Ltd. The deal secures all related technologies for the NeoAB33 novel drug project for a total consideration of RMB20 million (USD 2.6 million).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=35711\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/2012.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/2012.webp\",\"width\":1080,\"height\":608,\"caption\":\"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35711#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project - Insight, China&#039;s Pharmaceutical Industry","description":"Beijing Science Sun Pharmaceutical Co., Ltd (SHE: 300485) announced a Drug Technology Transfer Agreement with its equity-affiliated company Beijing Protein Innovation Co., Ltd. The deal secures all related technologies for the NeoAB33 novel drug project for a total consideration of RMB20 million (USD 2.6 million).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=35711","og_locale":"en_US","og_type":"article","og_title":"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project","og_description":"Beijing Science Sun Pharmaceutical Co., Ltd (SHE: 300485) announced a Drug Technology Transfer Agreement with its equity-affiliated company Beijing Protein Innovation Co., Ltd. The deal secures all related technologies for the NeoAB33 novel drug project for a total consideration of RMB20 million (USD 2.6 million).","og_url":"https:\/\/flcube.com\/?p=35711","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-06-20T07:37:37+00:00","article_modified_time":"2025-06-20T07:37:38+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2012.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=35711#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=35711"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project","datePublished":"2025-06-20T07:37:37+00:00","dateModified":"2025-06-20T07:37:38+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=35711"},"wordCount":177,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=35711#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2012.webp","keywords":["CVD","Science Sun Pharmaceutical","SHE: 300485"],"articleSection":["Company","Deals","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=35711#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=35711","url":"https:\/\/flcube.com\/?p=35711","name":"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=35711#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=35711#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2012.webp","datePublished":"2025-06-20T07:37:37+00:00","dateModified":"2025-06-20T07:37:38+00:00","description":"Beijing Science Sun Pharmaceutical Co., Ltd (SHE: 300485) announced a Drug Technology Transfer Agreement with its equity-affiliated company Beijing Protein Innovation Co., Ltd. The deal secures all related technologies for the NeoAB33 novel drug project for a total consideration of RMB20 million (USD 2.6 million).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=35711#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=35711"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=35711#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2012.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2012.webp","width":1080,"height":608,"caption":"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=35711#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/2012.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=35711"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35711\/revisions"}],"predecessor-version":[{"id":35714,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35711\/revisions\/35714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/35713"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=35711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=35711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=35711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}